Related Experiment Video
Updated: Feb 26, 2026
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
BRAF Mutation Status Concordance Between Primary Cutaneous Melanomas and Corresponding Metastases: A Review of the
E Godoy-Gijón1, M Yuste-Chaves2, Á Santos-Briz3
1Servicio de Dermatología, Complejo Asistencial de Zamora, Zamora, España.
Abstract:
The identification of B-Raf proto-oncongene (BRAF) mutation and the emergence of targeted therapy marked a turning point in the treatment of melanoma. The study of mutation status concordance between primary tumors and metastases in this cancer has major treatment implications as it facilitates the selection of candidates for targeted therapy. This review analyzes the evidence on the level of mutation status concordance between primary tumors and different types of metastases in cutaneous melanoma and provides an overview of the advantages and disadvantages of the various methods used to detect BRAF mutations.
Insights
BRAF mutation testing in melanoma is crucial. Concordance of BRAF mutation status between primary tumors and metastases aids in selecting patients for targeted therapy.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- BRAF proto-oncogene mutations are key drivers in melanoma.
- Targeted therapies offer new treatment avenues for melanoma patients.
- Understanding mutation status concordance is vital for effective treatment selection.
Purpose of the Study:
- To review evidence on BRAF mutation status concordance between primary cutaneous melanoma and its metastases.
- To analyze the implications of this concordance for targeted therapy selection.
- To compare methods for BRAF mutation detection.
Main Methods:
- Literature review of studies investigating BRAF mutation status in primary melanoma and metastases.
- Analysis of concordance rates across different metastatic sites.
- Overview of BRAF mutation detection techniques.
Main Results:
- Evidence on BRAF mutation status concordance between primary tumors and metastases is variable.
- Concordance has significant implications for patient stratification for targeted therapies.
- Various methods exist for BRAF mutation detection, each with pros and cons.
Conclusions:
- BRAF mutation status concordance is a critical factor in melanoma treatment.
- Accurate mutation detection and understanding concordance are essential for personalized medicine in melanoma.
- Further research may refine concordance understanding and diagnostic approaches.
